Drug Trial Radar · NCT05507216
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Last checked: Nov 19, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
636
Actual
Start
Jan 25, 2023
Primary completion
Jun 24, 2025
Study completion Jul 15, 2025
Sponsor
- Lead sponsor
- Abivax S.A.Industry
- Sponsor type
- Industry
- First posted
- Aug 18, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\].
Conditions
- Ulcerative Colitis
Interventions
ABX464Drug
Administered once daily in the morning with food
PlaceboDrug
Administered once daily in the morning with food
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Who Achieve Clinical Remission Per Modified Mayo Score at Week 8Time frame: 8 weeks
Locations
262 sites in 27 countries. Site status is shown where the registry gives one.
University of Alabama -Birmingham
Birmingham, Alabama
Research Solutions of Arizona, PC
Litchfield Park, Arizona
Applied Research Center of Arkansas
Little Rock, Arkansas
National Institute of Clinical Research
Bakersfield, California
Citrus Valley Gastroenterology
Covina, California
United Medical Doctors
Murrieta, California
Hoag Memorial Hospital Presbyterian
Newport Beach, California
Clinical Applications Laboratories
San Diego, California
Santa Maria Gastroenterology Medical Group
Santa Maria, California
Danbury Hospital
Danbury, Connecticut
West Central Gastroenterology d/b/a Gastro Florida
Clearwater, Florida
IHS Health
Kissimmee, Florida
Research Associates of South Florida
Miami, Florida
Sanchez Clinical Research, Inc
Miami, Florida
Wellness Clinical Research
Miami Lakes, Florida
Sarkis Clinical Trials - Parent
Ocala, Florida
AdventHealth Medical Group
Orlando, Florida
Arnold Palmer Hospital For Children
Orlando, Florida
Omega Research Orlando, LLC
Orlando, Florida
Advanced Medical Research Center
Port Orange, Florida
GCP Clinical Research, LLC
Tampa, Florida
University of South Florida - PARENT
Tampa, Florida
The University of Iowa
Iowa City, Iowa
Cotton O'Neil Clinical Research Center
Topeka, Kansas
Tandem Clinical Research, LLC
Marrero, Louisiana
University of Michigan
Ann Arbor, Michigan
Clinical Research Institute of Michigan, LLC
Chesterfield, Michigan
BVL Clinical Research
Liberty, Missouri
Premier Health Research
Sparta, New Jersey
NY Scientific Corp.
Brooklyn, New York
Mount Sinai
New York, New York
Plains Clinical Research Center, LLC
Fargo, North Dakota
Susquehanna Research Group, LLC
Harrisburg, Pennsylvania
Frontier Clinical Research, LLC
Uniontown, Pennsylvania
Rapid City Medical Center, LLC
Rapid City, South Dakota
Digestive Health Research, LC
Hermitage, Tennessee
Texas Clinical Research Institute, LLC
Arlington, Texas
Inquest Clinical Research
Baytown, Texas
Gastroenterology Consultants of South Texas, PA
Harlingen, Texas
Digestive System Healthcare
Pasadena, Texas
Showing 40 of 262 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.